BioSpace News Archive

Theralink Technologies, Inc., a precision medicine and molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, announced that the Company has received Clinical and Public Health License from the State of California for its Golden, Colorado laboratory, effective March 11th, 2021.

Hollister Incorporated, a global medical device company and US market share leader in Ostomy care has been awarded a contract for ostomy products with Vizient, Inc.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the publication of an article entitled “Amantadine ER (Gocovri®) significantly increases ON time without any dyskinesia: Pooled analyses from pivotal studies in Parkinson’s disease” in the peer-reviewed journal Frontiers in Neurology

HOYA Corporation (TSE:7741, “HOYA”) today confirms that the five year contract announced on July 6, 2020 for technical collaboration and supply of diagnostics ultrasound systems and ultrasound sensor with Hitachi, will become effective as of March 31st of 2021.

Horizon Therapeutics (Nasdaq: HZNP) and the Cubs today announced a Legacy Partnership that includes a Cubs STEAM Program, presented by Horizon, which will include an innovative, citywide science camp and fair that allows Chicagoland-area middle and high school students to explore the connection between science and baseball as well as showcase their STEAM talents

Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that an abstract featuring its leading C’Dot Drug Conjugate (CDC) candidate will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will take place virtually from April 10-15, 2021.

Valeo to commercialize Enerzair ® Breezhaler ® and Atectura ® Breezhaler ® , 2 innovative asthma therapies approved by Health Canada Positions Valeo as one of the leading Canadian Respiratory companies Almost 4 million Canadians afflicted with asthma 1 ; Canadian market for asthma medication exceeds $700M annually 2

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the annual general meeting on Wednesday 5 May 2021.

Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi).

Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “the Group"; Stock Code: 600196.SH, 02196.HK), a leading healthcare group in China, announced its annual results for the year of 2020 (“the Reporting Period”), together with its 2020 Corporate Social Responsibility (CSR) report.